-
Your RFQ cart is empty!
Buprenorphine
Venkatasai is a leading provider of pharmaceutical reference standards, specializing in the supply of high-purity Buprenorphine reference materials. Our portfolio includes both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine derivatives (N-NO products). These reference standards play a crucial role in pharmaceutical R&D, aiding in formulation development, ANDA/DMF submissions, quality control, method validation, stability studies, and impurity profiling—including the identification and assessment of potentially genotoxic impurities.
Each Buprenorphine-related product is rigorously characterized and delivered with a detailed Certificate of Analysis (COA) and comprehensive analytical data to ensure regulatory compliance. Upon request, we also offer EP/USP traceable standards. To maintain the highest quality standards, all materials are subject to periodic re-testing and continuous quality monitoring.
Buprenorphine EP Impurity A
Buprenorphine EP Impurity B
Buprenorphine EP Impurity C
Buprenorphine EP Impurity D
Buprenorphine EP Impurity E
Buprenorphine EP Impurity F
Buprenorphine EP Impurity G
Buprenorphine EP Impurity H
Buprenorphine EP Impurity I
Buprenorphine EP Impurity J
Buprenorphine N-oxide
10-Oxo Buprenorphine
Buprenorphine Nitrile
Buprenorphine 7-(S)-Epimer
Benzylmorphine
Buprenorphine Impurity 1
Norbuprenorphine D3
N-Nitroso Buprenorphine EP Impurity B
Buprenorphine Hydrochloride
Buprenorphine
Buprenorphine EP Impurity B (HCl)
